Urological infections significantly impact the wellbeing and quality of life of individuals owing to their widespread occurrence and diverse clinical manifestations. The objective of the guidelines panel was to provide evidence-based guidance on the diagnosis, treatment, and prevention of urinary tract infections (UTIs) and male accessory-gland infections, while addressing crucial public health aspects related to infection control and antimicrobial stewardship. For the 2024 guidelines on urological infections, new and relevant evidence was identified, collated, and appraised via a structured assessment of the literature. Databases searched included Medline, EMBASE, and the Cochrane Libraries. Recommendations within the guidelines were developed by the panel to prioritise clinically important care decisions. The strength of each recommendation was determined according to a balance between desirable and undesirable consequences of alternative management strategies, the quality of the evidence (including the certainty of estimates), and the nature and variability of patient values and preferences. Key recommendations emphasise the importance of a thorough medical history and physical examination for patients with urological infections. The guidelines stress the role of antimicrobial stewardship to combat the rising threat of antimicrobial resistance, providing recommendations for antibiotic selection, dosing, and duration on the basis of the latest evidence. This overview of the 2024 EAU guidelines offers valuable insights into managing urological infections and are designed for effective integration into clinical practice. The European Association of Urology has issued an updated guideline on urological infections. The guidelines provide recommendations for diagnosis, treatment, and prevention, with a particular focus on minimising antibiotic use because of the increasing global threat of antimicrobial resistance.

中文翻译：

---

欧洲泌尿外科协会泌尿系统感染指南：2024 年指南摘要


泌尿系统感染由于其广泛发生和多种临床表现，会显着影响个人的健康和生活质量。指南小组的目标是为尿路感染 （UTI） 和男性附属腺感染的诊断、治疗和预防提供循证指导，同时解决与感染控制和抗菌药物管理相关的关键公共卫生方面。对于 2024 年泌尿系统感染指南，通过对文献的结构化评估确定、整理和评估了新的和相关证据。检索的数据库包括 Medline、EMBASE 和 Cochrane 图书馆。该小组制定了指南中的建议，以优先考虑具有临床重要性的护理决策。每项建议的强度是根据替代管理策略的可取和不可取后果、证据质量（包括估计的质量）以及患者价值观和偏好的性质和可变性来确定的。主要建议强调了对泌尿系统感染患者进行全面病史和体格检查的重要性。该指南强调了抗菌药物管理在应对日益增长的抗菌素耐药性威胁方面的作用，并根据最新证据为抗生素的选择、剂量和持续时间提供了建议。2024 年 EAU 指南的概述为管理泌尿系统感染提供了有价值的见解，旨在有效整合到临床实践中。欧洲泌尿外科协会 （European Association of Urology） 发布了更新的泌尿系统感染指南。 该指南提供了诊断、治疗和预防的建议，特别关注尽量减少抗生素的使用，因为全球抗微生物药物耐药性的威胁日益严重。